These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1653645)

  • 21. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.
    Ohishi M; Ueda M; Rakugi H; Okamura A; Naruko T; Becker AE; Hiwada K; Kamitani A; Kamide K; Higaki J; Ogihara T
    Circulation; 1997 Nov; 96(10):3328-37. PubMed ID: 9396424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina.
    Nishimoto Y; Miyazaki Y; Toki Y; Murakami R; Shinoda M; Fukushima A; Kanayama H
    J Am Coll Cardiol; 1998 Nov; 32(6):1624-9. PubMed ID: 9822088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial management and long-term clinical outcome of restenosis after initially successful percutaneous transluminal coronary angioplasty.
    Weintraub WS; Ghazzal ZM; Douglas JS; Liberman H; Morris DC; Cohen CL; King SB
    Am J Cardiol; 1992 Jul; 70(1):47-55. PubMed ID: 1615869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K
    Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
    Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between morphology of restenosis and clinical aspects in patients who had undergone coronary angioplasty].
    Bramucci E; de Servi S; Ghio S; Cioffi P; Angoli L; Barberis P; Ferrario M; Poma E; Ardissino D; Montemartini C
    G Ital Cardiol; 1988 Oct; 18(10):819-23. PubMed ID: 2977595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris.
    Halon DA; Merdler A; Shefer A; Flugelman MY; Lewis BS
    Am J Cardiol; 1989 Aug; 64(5):289-93. PubMed ID: 2526992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up after percutaneous transluminal coronary angioplasty in patients with single-vessel disease.
    Kadel C; Vallbracht C; Buss F; Kober G; Kaltenbach M
    Am Heart J; 1992 Nov; 124(5):1159-69. PubMed ID: 1442481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.
    Parisi AF; Folland ED; Hartigan P
    N Engl J Med; 1992 Jan; 326(1):10-6. PubMed ID: 1345754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of angiographic coronary restenosis after percutaneous transluminal coronary angioplasty (PTCA): usefulness of angina combined with rest electrocardiogram.
    Gottschall CA; Miler V; Castro I; Rodrigues R
    J Invasive Cardiol; 1999 Jul; 11(7):403-9. PubMed ID: 10745562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restenosis and its determinants in first and repeat coronary angioplasty.
    Rapold HJ; David PR; Guiteras Val P; Mata AL; Crean PA; Bourassa MG
    Eur Heart J; 1987 Jun; 8(6):575-86. PubMed ID: 2957201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty.
    Stone GW; Rutherford BD; McConahay DR; Johnson WL; Giorgi LV; Ligon RW; Hartzler GO
    Cathet Cardiovasc Diagn; 1989 Dec; 18(4):227-31. PubMed ID: 2691100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent ischemia more than 1 year after successful percutaneous transluminal coronary angioplasty. An analysis of the extent and anatomic pattern of coronary disease.
    Bottner RK; Green CE; Ewels CJ; Recientes E; Patrissi GA; Kent KM
    Circulation; 1989 Dec; 80(6):1580-4. PubMed ID: 2598421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.